Comparing Nanovibronix (FEED) & The Competition

Nanovibronix (NASDAQ:FEED) is one of 27 publicly-traded companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it contrast to its peers? We will compare Nanovibronix to related companies based on the strength of its profitability, earnings, dividends, institutional ownership, analyst recommendations, valuation and risk.

Risk & Volatility

Nanovibronix has a beta of 2.26, indicating that its stock price is 126% more volatile than the S&P 500. Comparatively, Nanovibronix’s peers have a beta of 1.80, indicating that their average stock price is 80% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nanovibronix and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.04
Nanovibronix Competitors	$62.62 million	-$29.77 million	1.59

Nanovibronix’s peers have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Nanovibronix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-500.48%	-110.93%	-48.62%

Insider and Institutional Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 5.2% of Nanovibronix shares are owned by company insiders. Comparatively, 19.9% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations for Nanovibronix and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	82	89	199	7	2.35

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 53.02%. Given Nanovibronix’s peers stronger consensus rating and higher possible upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its peers.

Summary

Nanovibronix peers beat Nanovibronix on 8 of the 13 factors compared.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.